Marshall S J, Russell P F, Wright C W, Anderson M M, Phillipson J D, Kirby G C, Warhurst D C, Schiff P L
Department of Pharmacy, University of Brighton, United Kingdom.
Antimicrob Agents Chemother. 1994 Jan;38(1):96-103. doi: 10.1128/AAC.38.1.96.
Twenty-four bisbenzylisoquinoline alkaloids were screened for antiplasmoidal, antiamoebic, and cytotoxic activities by use of in vitro microtests. Eight of the alkaloids had antiplasmodial activity, with a 50% inhibitory concentration (IC50) of less than 1 microM against a multidrug-resistant strain of Plasmodium falciparum (chloroquine had an IC50 of 0.2 microM). The three alkaloids most active against Entamoeba histolytica, aromoline, isotrilobine, and insularine, had IC50s of 5 to 11.1 microM (metronidazole had an IC50 of 1.87 microM). None of the 24 bisbenzylisoquinoline alkaloids exhibited significant cytotoxicity against the KB cell line, the most toxic being berbamine, with an IC50 of 17.8 microM (the IC50 of podophyllotoxin was 0.008 microM). Bisbenzylisoquinoline alkaloids merit further investigation as potential novel antimalarial agents.
通过体外微量试验对24种双苄基异喹啉生物碱进行了抗疟原虫、抗阿米巴和细胞毒性活性筛选。其中8种生物碱具有抗疟原虫活性,对一株耐多药恶性疟原虫的半数抑制浓度(IC50)小于1微摩尔/升(氯喹的IC50为0.2微摩尔/升)。对溶组织内阿米巴最具活性的3种生物碱,即芳啉、异三叶豆碱和海岛藤碱,其IC50为5至11.1微摩尔/升(甲硝唑的IC50为1.87微摩尔/升)。24种双苄基异喹啉生物碱中无一对KB细胞系表现出显著的细胞毒性,毒性最大的是小檗胺,其IC50为17.8微摩尔/升(鬼臼毒素的IC50为0.008微摩尔/升)。双苄基异喹啉生物碱作为潜在的新型抗疟药物值得进一步研究。